![](https://www.ictbio.com/wp-content/uploads/2020/01/Lu-Victor-LF2_1443-a-cts.jpg)
Victor Xiaobin Lu, Ph.D.
CTO
Chair of FDA review committee for Kymriah, the first CAR-T BLA.
10 years of FDA cellular and gene therapy review experience.
7 years of R&D experience at VIRxSYS Corp.
Postdoctorate at UCSF.
Ph.D. from State University of New York.
US based.